Credit Suisse’s CVS Health CVS Stock Holding History

Credit Suisse’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-650,500	Closed	-$67.1M	–	3749
2021 Q4	$67.1M	Sell	650,500 -168,000	-21%	-$15.5M	0.04%	513
2021 Q3	$69.5M	Buy	818,500 +78,500	+11%	+$6.58M	0.04%	501
2021 Q2	$61.8M	Sell	740,000 -16,900	-2%	-$1.38M	0.03%	583
2021 Q1	$56.9M	Buy	756,900 +137,300	+22%	+$10M	0.03%	650
2020 Q4	$42.3M	Sell	619,600 -47,300	-7%	-$3.08M	0.02%	790
2020 Q3	$38.9M	Buy	666,900 +344,300	+107%	+$21.4M	0.02%	713
2020 Q2	$21M	Buy	322,600 +100,000	+45%	+$6.3M	0.02%	916
2020 Q1	$13.2M	Sell	222,600 -18,000	-7%	-$1.2M	0.01%	1038
2019 Q4	$17.9M	Buy	240,600 +140,600	+141%	+$9.87M	0.01%	1095
2019 Q3	$6.31M	Buy	+100,000	New	+$5.93M	0.01%	1587
2019 Q1	–	Sell	-20,500	Closed	-$1.34M	–	3999
2018 Q4	$1.34M	Buy	+20,500	New	+$1.53M	﹤0.01%	2554
2018 Q1	–	Sell	-25,000	Closed	-$1.81M	–	3983
2017 Q4	$1.81M	Buy	+25,000	New	+$1.82M	﹤0.01%	2510
2017 Q2	–	Sell	-200,000	Closed	-$15.7M	–	3846
2017 Q1	$15.7M	Buy	+200,000	New	+$16M	0.01%	962
2015 Q2	–	Sell	-87,000	Closed	-$8.98M	–	4528
2015 Q1	$8.98M	Buy	+87,000	New	+$8.8M	0.01%	1268

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse's CVS Position: Q1 2024 in Review

Credit Suisse reduced its CVS Health (CVS) stake by 5.3% in Q1 2024, selling an estimated $6.68M and leaving 1,549,136 shares worth $124M. The position accounts for 0.12% of the portfolio, ranked #155.

Credit Suisse first reported a position in CVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $456M in Q4 2014. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

Credit Suisse held 1,549,136 shares of CVS Health worth $124M as of Q1 2024.
Credit Suisse sold 87,468 CVS Health shares in Q1 2024, an estimated $6.68M.
CVS Health made up 0.12% of Credit Suisse's portfolio in Q1 2024, its #155 holding.
Credit Suisse first reported a position in CVS Health in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's CVS Health position peaked at $456M in Q4 2014.
2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.